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Summary.-The Familial Atypical Multiple Mole-Melanoma Syndrome (FAMMM)
is characterized by an autosomal dominantly inherited susceptibility to multiple
atypical naevi. Patients with this hereditary phenotype show a strong susceptibility
to cutaneous malignant melanoma (CMM). Our investigation of an extended Dutch
kindred showing the FAMMM phenotype revealed a proband with bilateral intra-
ocular malignant melanoma (IOM) and multiple CMM. The family revealed an array
of tumours which included carcinoma ofthe lung, skin, larynx, and breast in addition
to CMM and IOM, which were transmitted vertically through 3 generations. There
was male-to-male transmission, and the number of affected males and females was
about the same, which was consistent with an autosomal dominant inheritance. Thus
the FAMMM syndrome not only indicates a potential for CMM, but a susceptibility
to other systemic cancers as well. These observations, though limited to a single kin-
dred, merit a painstaking evaluation of cancer ofall anatomical sites in other kindreds
showing the FAMMM syndrome. Such studies could yield clues to cancer aetiology,
pathogenesis, and control.
IN THEIR HISTORICAL REVIEW of here-
ditary malignant melanoma, Greene &
Fraumeni (1979) credit a case study by
Norris (1820) with being possibly the first
accurate description of the hereditary
form of this tumour. In this family,
melanoma appeared in a 59-year-old man.
Thirty years before his death his father
also died of a similar disease. Reportedly,
a surgeon who had attended this patient's
father observed that he had many moles
on various parts of his body and that his
children, including the index patient, had
multiple moles scattered over their bodies.
These observations led this surgeon to
suggest that the disease was hereditary.
This may have been the first example of
the familial atypical multiple mole-mela-
noma syndrome (FAMMM) (Lynch et al.,
1978, 1980; Frichot et al., 1977), which has
also been referred to by the following
names: the B-K Mole Syndrome (Greene
& Fraumeni, 1979; Clark et al., 1978;
Reimer et al., 1978) th-e Dysplastic Naevus
Syndrome (DNS) (Elder et al., 1980) and
the Large Atypical Naevus Syndrome
(LANS) (Bondi et al., 1981).
The next account of familial melanoma
did not appear until 1952, when Cawley
et al., described cutaneous malignant
melanomas (CMM) in a father and 2 of his
3 children.
The FAMMM syndrome has hitherto
been discussed primarily from the stand-
point of its propensity to CMM. However,
recent evidence suggests that it may be
associated with other histological varieties
of cancer, including intraocular malignant
melanoma (IOM) (Greene & Fraumeni,
1979; Lynch et al., 1975, 1980; Lynch &
Fusaro, 1981; Lynch & Krush, 1968).
The purpose ofthis report is to describeH. T. LYNCH ET AL.
a Dutch kindred in which, in addition to
the FAMMM syndrome and CMM, several
histological varieties ofcancerwere present
in 3 generations, including in one patient
bilateral IOM and multiple CMM.
MATERIAL AND METHODS
This kindred was originally studied by
Lynch et al. (1975) through a survey of medi-
cal records, with few pathological documenta-
tions of cancer. Subsequently, a high-risk
relative with the extraordinary occurrence of
bilateral IOM and multiple CMM was seen by
one of us (J.A.G.) in Leiden, Holland. The
patient's knowledge ofthe previous investiga-
tion ofhis family led to this second ascertain-
ment. The present study was then initiated,
in part on the suspicion that this kindred
might manifest the FAMMM syndrome.
Three members of the Cancer Genetics
Team from the Institute for Familial Cancer
Management and Control, Inc., Creighton
University, a dermatologist (R.M.F.), a
clinical oncologist-geneticist (H.T.L.), and a
research nurse (J.F.L.), visited the family in
Holland, where the study was undertaken in
collaboration with a Dutch ophthalmologist
(J.A.G.) and a human geneticist (L.N.W.).
A number of the affected family members
had been known for many years at the
Netherlands Cancer Hospital in Amsterdam
(P.R., H.N.).
During the visit to Holland by the U.S.
research team, cutaneous examinations were
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performed on 14 relatives who were either
previously affected with melanoma or who
by virtue of their position in the pedigree
might be at risk of developing this disease.
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ently by a dermatopatholo- Table I is the tumour registry which also provides the basis for the authenticity of
the malignant lesions. Table II contains our sites (all ascertained by findings relevant to the FAMMM syn-
the pedigree shown in drome and malignant melanoma of all
family members that were seen in 1979-80
Age at by the Creighton-Dutch investigators.
Tumour di2agnosis Six ofthe 12 family members examined
45 ° had numerous atypical multiple naevi
61 51 characteristic of the FAMMM syndrome.
60 The atypical naevi showed varying colours
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66 uniform colour distribution within the
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22 Patient 111-8, the index case who led to
the second ascertainment of this family,
nical/histological findings was born in 1921. Separate primary malig-
in patients seen in 1979 nant melanomas were removed from the
skin of his scalp in 1974, and from his
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moles removed after discovery mitted for publication.
oma. Fig. 2 is a photomicrograph of a lesion
from the abdomen of Patient IV-5. This
was a compound naevus. The melanocytes
iveonlyforthemolesexamined at the dermal-epidermal junction showed
ude a diagnosis ofFAMMM. mild dysplasia. The papillary dermis
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FIG. 2.-Compound naevus. Focal dysplasia ofmelanocytes at dermal-epidermal junction. H. & E. x 10
(original magnification).
Fig. 3.-Compound naevus showing mild dysplasia of melanocytes at dermal-epidermal junction and chronic inflammation in the dermis. H. & E. x 10 (original magnification).
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FIG. 4.-Dysplasia of melanocytes, mild fibroplasia and chronic inflammation of the papillary dermis.
H. & E. x 25 (original magnification).
showed some fibroplasia. There was focal
perivascular chronic inflammatory-cell in-
filtrate. This lesion had some of the histo-
pathological features of an atypical mole
in the FAMMM syndrome.
Histological sections of 4 previously
removed moles from another member of
the pedigree (Fig. 1, IV-6) showed naevo-
cellular compound naevi, with mild to
moderate dysplasia of the melanocytes
at the dermal-epidermal junction. There
was some mild fibroplasia, new blood-
vessel formation, and chronic inflamma-
tion within the papillary dermis (Figs
3, 4). Histology of these lesions suggested
FAMMM moles.
There were 2 patients (11-1 I and 111-12)
with malignant melanomas without signs
of the FAMMM syndrome, 4 (111-9, IV-6
IV-8 and IV-10) with the FAMMM clinical
phenotype without melanomas, and 3 with
both (11-7, 111-8 and IV-5). There was
sufficient agreementbetweenthepathology
and/or the clinical findings to accept the
diagnosis ofFAMMM syndrome in at least
7 patients (11-7, 111-8, III-9, IV-5, IV-6,
IV-8, and IV-10). In Patient IV-9 there
was no clinical evidence of atypical moles
at our examination, but suspicious moles
had been removed previously. Otherfamily
members who were not seen personally
(notably IV-12 and IV-13) are reported by
relatives to have numerous moles, said to
be "birthmarks". Their significance re-
mains obscure.
DISCUSSION
When studying the pedigree (Fig. 1) and
Tables I and II, it becomes evident that a
single autosomal dominant gene can best
explain cancer transmission in this family.
The deleterious gene may be responsible
for malignant melanoma alone, for the
FAMMM phenotype alone, or for both.
Age is not a precipitating factor, since
FAMMM stigmata and/or cancer may be
present individually or together in younger
and older individuals. For example, 11-11,
who is now aged 75, apparently never had
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moles, but had a skin lesion removed from
her left foot which histologically was
malignant melanoma. It is important to
recognize, however, that she had her left
breast removed at the age of 66 for a
primary adenocarcinoma of the breast. In
the case of 11-7, who died at the age of 84,
a number of clinical and histological data
were available from some of the 20 opera-
tions he underwent for numerous malig-
nant lesions, including malignant mela-
noma. He had FAMMM moles and squa-
mous-cell cancer of the pharynx and
larynx with metastases. These observa-
tions are consistent with the assumption
that malignant melanoma and other
malignancies in this family are compatible
with variable age of onset and apparent
long survival.
The possibility of associated cancer in
addition to CMM and IOM in FAMMM is
supported by another unrelated family
ascertained by us only recently. In this
U.S. kindred, a 28-year-old white female,
who was an occasional mild smoker and
non-alcoholic, had squamous-cell car-
cinoma (histologically verified) of the
tonsillar pillar and superficial spreading
malignant melanoma (Clark's level II)
from the skin of her shoulder. Her father
had a nodular Clark's level IV malignant
melanoma excised from the skin of his
back at the age of 28. At 54 he manifested
histologically verified adenocarcinoma of
the prostate gland, and squamous-cell
carcinoma ofthe lung at 59. Occurrence of
cancer, including CMM, and findings con-
sistent with a FAMMM mole in a single
patient, have been verified in additional
members of this kindred through 2
generations.
Lynch (1980) hasestimatedthatprimary
genetic factors contribute to the aetiology
of 5-10% of all human cancers. In turn,
it has been estimated that - 900 of the
2000 or more Mendelian inherited diseases
of man have cancer association (Mulvihill,
1977), and, of the genodermatoses, more
than 50 have a significant cancer associa-
tion (Lynch & Fusaro, 1981). When a
search for cancer of all anatomical sites
is made in certain hereditary cancer
syndromes, one frequently observes a
variety of malignant neoplastic lesions
which constitute integral components of
the particular syndrome, i.e., adenocar-
cinoma of the colon, small bowel and
stomach, and sarcomas in Gardner's
syndrome; phaeochromocytoma, malig-
nant glioma and neurofibrosarcoma in von
Recklinghausen's neurofibromatosis; leu-
kaemia, lymphosarcoma, reticulum-cell
sarcoma, squamous-cell carcinoma of the
tongue and oesophagus and adenocar-
cinoma of the colon in Bloom's syndrome
(Lynch, 1975).
Carcinoma of the lung, skin, larynx and
breast, in addition to the extraordinary
occurrence of bilateral IOM and multiple
CMM in one of the relatives (111-8) and
CMM in others, were found in our kindred
(Fig. 1). However, since this is a single
kindred, these observations must be inter-
preted with caution. As in any family unit,
there can only be a limited number of
individuals at risk for cancer. In order to
assess the true tumour spectrum of the
FAMMM syndrome more fully, we need
a painstaking evaluation of cancer of all
anatomic sites in a large number of these
families. Further compounding this issue
is the fact that cancer is common, and
therefore by chance alone one should
encounter some of the neoplastic lesions
within any large family.
Greene & Fraumeni (1979) have re-
viewed the problem ofassociated cancer in
20 melanoma-prone families. They ob-
served that the most frequently cited
malignant neoplasms were nonmelanoma
skin cancer, cancers of the lung, breast,
stomach, pancreas, large bowel and endo-
metrium. However, no consistent patterns
of cancer association emerged from this
review.
There have been 5 reports (Lynch &
Krush, 1968; Turkington, 1965; Grimst-
vedt, 1969; Bellet et al., 1980; Rodriguez-
Sains, 1980) involving 5 families in which
IOM and CMM have occurred in high-risk
members of each kindred. Thus with the
present report there are now at least 6
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families in which 10M and CMM have
occurred and in 2 of these-namely, the
present kindred and one reported by
Bellet et al. (1980) IOM and CMM have
occurred as separate primaries in the same
patients. Finally, Lynch & Fusaro (1981)
have studied a kindred with a xeroderma
pigmentosum-like syndrome in which IOM
and CMM have occurred as separate
primaries in sisters. The sister with IOM
at the age of 32 died at 38. Necropsy
revealed an adenocarcinoma of the ovary
(In preparation).
Precursor FAMMM moles may be identi-
fiable as early as 2 years of age (Lynch
et al., 1980). Their histology, while not
diagnostic, may nevertheless aid in assess-
ing genotype status, thereby providing a
highly reliable estimate of susceptibility
to CMM, as well as to various other forms
of cancer, including IOM and possibly
breast, lung, and laryngeal cancer, as
observed in the family in this communica-
tion. Given this knowledge, intensive sur-
veillance should not only be focused upon
skin signs, but other high-risk target
organs as well.
In conclusion, we have encountered an
excess of certain extraordinary biological
and pathological phenomena in cancer-
prone kindreds: viz., spontaneous regres-
sion of metastatic malignant melanoma
in 2 siblings with xeroderma pigmentosum
(Lynch et al., 1978), significant 5-year
survival advantage in hereditary breast
and nonpolyposis colon cancer (Lynch
et al., 1981), and now the remarkable
occurrence of bilateral IOM and multiple
CMM in Case 111-8. We therefore believe
that studies of cancer-prone families like
the present FAMMM kindred could prove
rewarding in yielding clues to cancer
aetiology, pathogenesis, and control.
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AI)DENDUM
Through the courtesy of Dr R. R. Hook,
University of Missouri, Columbia, we have
had an opportunity to evaluate malignant
melanoma in the Sinclair miniature swine
colony (Oxenhandler, R. W., Adelstein,
E. H., Haigh, J. P., Hook, R. R., Jr. &
Clark, W. H. (1979). Malignant melanoma
in the Sinclair miniature swine: An
autopsy study of 60 cases. Am. J. Pathol.,
96, 707.) Interestingly, these animals have
an excess of congenital malignant mela-
noma, multiple primary melanoma, mul-
tiple nevi, and a high rate of spontaneous
regression of malignant melanoma. Pre-
liminary evaluation of their premelanotic
nevi by us showed histologic similarities to
FAMMM moles. These animals may well
provide a model for the study of the
FAMMM syndrome.